Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine...
Sanofi and GSK today started the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine....
Clinerion and Maxer Consulting partner to boost the identification and the recruitment of patients...
Clinerion's Patient Network Explorer will leverage Maxer's extended network of relations in the international healthcare...
Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart...
Bayer announced the submission of the regulatory application seeking the approval of vericiguat in China....
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India
Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started...
Australian COVID-19 vaccine shows promising results in animal trials
A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results...
Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient...
Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced...
AstraZeneca Phase I clinical trial initiated for COVID-19 monoclonal antibody
The first participants have been dosed in a Phase I trial of AZD7442, a combination...
BMS Provides Update on Phase 3 IDHENTIFY Trial in Patients with Relapsed or Refractory...
Bristol Myers Squibb announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus best...
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment...
Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in...
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
